Shogo Matsuda

Has grant

Osaka Medical and Pharmaceutical University
Country flagJapan

Research Interests

Explore related searches

Contact this professor

Get a free first email built on one of their papers, ready for you to edit and send yourself.

Recent Grants

Grant: Close

Role of Fractalkine in the Pathogenesis of Microscopic Polyangiitis-associated Interstitial Lung Disease

Open Date: 2024-05-01

Close Date: 2025-04-01

Grant: Close

Exploring Novel Biomarkers for Microscopic Polyangiitis with ILD by Comprehensive Analysis of miRNA and mRNA in CD68+/CD163+ Macrophages

Open Date: 2023-04-01

Close Date: 2025-03-01

Articles (10)

Year:

2024

Year:

2024

Objective This study aimed to establish prediction models for respiratory-related mortality in microscopic polyangiitis (MPA) complicated by interstitial lung disease (ILD) using clinical characteristics. Methods We enrolled patients with MPA with ILD between May 2005 and June 2021 in a multicentre cohort of Japanese patients with MPA (REVEAL cohort). We evaluated the demographic, clinical, laboratory, radiological findings, treatments and the presence of honeycombing 1 cm above the diaphragm using chest high-resolution CT (HRCT) on admission. We explored the risk factors predictive of respiratory-related mortality. Results Of 115 patients, 26 cases died of respiratory-related diseases during a median follow-up of 3.8 years. Eighteen patients (69%) died due to respiratory infection, three (12%) had diffuse alveolar haemorrhage, and five (19%) had exacerbation of ILD. In univariate analysis, older age, lower percent forced vital capacity (%FVC), lower percent diffusing capacity of carbon monoxide (%DLCO), and the presence of honeycombing in the right lower lobe were identified as risk factors. Additionally, in multivariate analysis adjusted for age and treatment, %FVC, %DLCO and the presence of honeycombing in the right lower lobe were independently associated with respiratory-related mortality. We created prediction models based on the values of %FVC, %DLCO and presence of honeycombing on chest HRCT (termed “MPF model”). The 5-year respiratory-related death-free rate was significantly different between patients with MPA with ILD stratified by the number of risk factors based on the MPF model. Conclusions Our study indicates that the MPF model may help predict respiratory-related death in patients with MPA with ILD.

Year:

2023

Year:

2023

Year:

2023

Year:

2023

Year:

2022

Year:

2022

Year:

2022

Year:

2021

Collaborators (4)

Daisuke Nishioka

Assistant Professor

Osaka Medical and Pharmaceutical University

JAPAN
View details

Tomoki Taniguchi

Kyoto University Hospital

JAPAN
View details

Takashi Saito

Assistant Professor

Osaka Medical and Pharmaceutical University

JAPAN
View details

Tohru Takeuchi

Osaka Medical and Pharmaceutical University

JAPAN
View details
ApplyKite TwinLearns as you apply

Make your next move.

Prepare your application

Review drafts before you send them.